drugset / Trial / NCT00772863
Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy and the safety of the treatment.
Timeline
- Start
- 2003-09
- Primary completion
- 2008-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 100 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 100 mg/m2 | — |